Connect with us

Sci/tech

Electric car sales in India to reach 1.3-1.5 lakh in FY25: Report

Published

on

Mumbai, June 25 (IANS) With an improving adoption rate, electric car sales in India are likely to reach 1.3-1.5 lakh in the current fiscal year (FY25), according to a CareEdge Rating report.

After a record growth of 90 per cent with volumes at 90,432 units in FY24, the electric car penetration is consistently increasing in the country, driven by the government’s efforts towards a more sustainable, environmentally friendly, and efficient transportation sector.

The shift to electric mobility extends beyond cars and trucks and e-rickshaws and e-karts are also gaining popularity across the country.

As per the report, the overall passenger vehicles (PV) industry is expected to exhibit moderate volume growth of around 3-5 per cent in FY25, on account of a high-base effect of FY24, shrinking order book and expectation of persistently subdued demand for entry-level variants in FY25.

“Strong demand for new model launches and SUVs coupled with the expectation of interest rate cuts in the second half of FY25 is expected to keep the sales momentum rolling,” said Arti Roy, Associate Director at CareEdge Ratings.

ALSO READ:  Paytm denies reports of sale of wallet business, says 'market speculation'

For the past decade, the utility vehicle (UV) segment has consistently outperformed the PV industry growth rate.

In FY24, for the first time, UV sales volume stood higher than passenger cars and vans.

Currently, UVs account for over 55 per cent of all new PV sales, and their share in overall PV sales is expected to further rise over the medium term, according to the report.

“While the market for premium vehicles is predicted to thrive, driven by a surge in demand for luxury and high-end models, entry-level variants are likely to see continued diminished demand due to a downturn in both rural and urban markets,” said Hardik Shah, Director at CareEdge Ratings.

–IANS

na/uk

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Sci/tech

Indian startups raised nearly $176 million across 16 deals in July 1st week

Published

on

By

New Delhi, July 6 (IANS) The Indian startup ecosystem raised nearly $176 million in funding across 16 deals in the first week of this month.

In the biggest funding round, fashion e-commerce platform Purplle secured $120 million led by Abu Dhabi Investment Authority.

Agri-tech startup Arya.ag also announced to raise $29 million led by impact investment firm Blue Earth Capital.

Video telematics startup Cautio also announced a pre-seed raise of Rs 6.5 crore led by Antler, 8i Ventures and AU Small Finance Bank.

Homegrown startups have raised nearly $7 billion in funding during the first half (H1) of 2024, more than the $5.92 billion raised in H1 2023.

Also, the fintech ecosystem achieved a significant milestone in the first half of this year by ranking among the top three funded globally, alongside the US and the UK.

–IANS

na/uk

ALSO READ:  Musk asks X users to post long-form articles to promote citizen journalism
Continue Reading

Sci/tech

Facing unexplainable mood disorders? You may be low on Vitamin B 12: Doctors

Published

on

By

New Delhi, July 6 (IANS) Vitamin B-12 plays a key role in producing brain chemicals that affect mood and other brain functions, said doctors on Saturday.

Vitamin B-12 (also known as cobalamin) plays a crucial role in the formation of red blood cells, cell metabolism, nerve function, and the production of DNA.

Some common symptoms of Vitamin B12 deficiency include strange sensations, numbness, or tingling in the hands, legs, or feet, difficulty walking (staggering, balance problems), anaemia, difficulty thinking and reasoning (cognitive difficulties), memory loss, weakness, or fatigue.

“Vitamin B-12 and other B vitamins play a crucial role in producing brain chemicals that affect mood and other brain functions. Low levels of B-12, as well as other B vitamins like vitamin B-6 and folate, may be linked to depression,” Dr Anshu Rohtagi, Senior Consultant, Department of Neurology, Sir Ganga Ram Hospital, told IANS.

“The deficiencies can result from poor diet or difficulties in absorbing the vitamins consumed. So, maintaining adequate B-12 level is essential for overall well-being, including mood regulation,” she added.

ALSO READ:  Samsung sets up development team for high bandwidth memory chips

Vitamin B-12 is majorly found in poultry, meat, fish, and dairy products. It is available as an oral supplement, as injections, or nasal spray.

People who consume a vegetarian or vegan diet may be more prone to deficiency as plant foods do not contain vitamin B-12. The elderly and people with digestive tract conditions that affect the absorption of nutrients also are susceptible to vitamin B-12 deficiency.

“Vitamin B12 plays a crucial role in producing brain chemicals like serotonin, which helps regulate mood. When B12 levels dip, these chemicals can become imbalanced, potentially leading to symptoms like mood swings, irritability, and even depression,” Dr Guruprasad Hosurkar, Additional Director – Neurology, Fortis Hospital, Bannerghatta Road, Bengaluru, told IANS.

Importantly, the doctor explained that the “connection is not gender-specific. Both men and women can experience mood changes due to B12 deficiency”.

While research is ongoing, studies suggest a link between low B12 and depression, with some showing improvement in mood with B12 supplementation.

ALSO READ:  PPBL demonstrates efficient resolution of customer issues within days

However, it’s important to note that mood swings can have many causes, and a doctor should be consulted to rule out other factors and determine if a B12 deficiency is present, Dr Guruprasad said.

“Vitamin B12 deficiency causes several neurological symptoms such as tingling, numbness & burning of feet, imbalance, memory impairment, mood disorders, psychosis, seizures, and Parkinsonism,” explained Dr Sudhir Kumar, from Indraprastha Apollo Hospitals, Hyderabad in a post on social media platform X.

“In a patient presenting with neurological or psychiatric symptoms, suspect vitamin B12 deficiency as a cause (especially if there is no obvious cause identified). Early diagnosis and prompt initiation of treatment rapidly improves patient’s symptoms,” he added.

The doctors also stressed the need to maintain a healthy lifestyle and advised key behaviours such as managing high blood pressure, and blood sugar, quitting smoking, and alcohol, staying physically active, getting adequate sleep, and managing stress.

–IANS

rvt/uk

Continue Reading

Sci/tech

Former NASA astronaut Steve Lee Smith to headline Kerala AI conclave

Published

on

By

Kochi, July 6 (IANS) Former NASA astronaut and technology executive Steve Lee Smith will be the highlight of the two-day first International GenAI Conclave to be hosted by the Kerala Government in Kochi on July 11 and 12.

This event is in association with IBM. Chief Minister Pinarayi Vijayan will inaugurate it.

A veteran astronaut, Smith flew into space four times at 28,000 KMH on the space shuttle during his stint in NASA, covering 16 million miles.

He also performed seven spacewalks, including repairs of the Hubble Space Telescope.

Smith will speak on ‘Lessons Learned from A Skywalker’ at the conclave.

The event will be attended by leading lights in this area to explore the transformative potential of AI and its impact on society and the economy.

The GenAI conclave aims to transform Kerala as an AI destination and showcase the state’s perspectives on industry 4.0, besides giving a thrust to the growth of the economy.

ALSO READ:  PM Modi-led Cabinet approves over Rs 10,000 crore to boost India's AI ecosystem

Besides developers, universities, students, media and analysts, the conclave will feature demos, activations, interactions with industry experts, panel discussions and lectures.

Participants will also get a first-hand experience in the latest advancements in the AI sector.

–IANS

sg/kvd

Continue Reading

Sci/tech

Mice with functional humanised immune system shows promise

Published

on

By

New Delhi, July 6 (IANS) A first-of-its-kind mice model with a fully functional human immune system and a human-like gut microbiome has shown promise of mounting specific antibody responses.

To date, researchers have not developed a fully functional human immune system, but only those with a brief lifespan that do not mount efficient immune responses, making them unsuitable for the development of in vivo human immunotherapies, human disease modelling, or human vaccine development.

Developed by scientists at The University of Texas in the US, the new model will overcome limitations of currently available in vivo human models and is a breakthrough for biomedical research and promises new insight into immunotherapy development and disease modelling.

Detailed in the journal Nature Immunology, the new humanised mice, called TruHuX (for truly human, or THX), possess a fully developed and fully functional human immune system, including lymph nodes, germinal centres, thymus human epithelial cells, human T and B lymphocytes, memory B lymphocytes, and plasma cells making highly specific antibody and autoantibodies identical to those of humans.

ALSO READ:  PM Modi-led Cabinet approves over Rs 10,000 crore to boost India's AI ecosystem

THX mice mount mature neutralising antibody responses to Salmonella Typhimurium and SARS-CoV-2 virus Spike S1 RBD after vaccination with Salmonella flagellin and the Pfizer Covid-19 mRNA vaccine, respectively.

It is also amenable to developing full-fledged systemic lupus autoimmunity after an injection of pristane — an oil that triggers an inflammatory response.

“THX mice provide a platform for human immune system studies, development of human vaccines, and testing of therapeutics,” said Paolo Casali, Professor at the University of Texas School of Medicine in San Antonio, US.

They do this “by critically leveraging oestrogen activity to support human stem cell and human immune cell differentiation and antibody responses”, he added.

–IANS

rvt/svn

Continue Reading

Sci/tech

Atal Innovation Mission empowering innovators in Tier 2 & 3 cities: Director

Published

on

By

New Delhi, July 6 (IANS) Atal Innovation Mission’s (AIM) Community Innovator Fellows (CIFs) programme is empowering innovators in Tier 2 and Tier 3 cities, said Dr. Chintan Vaishnav, Mission Director at AIM.

He said this while delivering a keynote address at NITI Aayog marking the celebration of the graduation of its second batch of CIFs on Friday.

Dr. Chintan underscored the programme’s pivotal role in advancing solutions across healthcare, education, agriculture, and financial services, resonating deeply with the ethos of sustainable development.

“We have now established robust institutions that seamlessly integrate business incubation with academia. This well-designed project aspires to be a model of excellence,” Dr. Vaishnav said.

He noted that the Community Innovator initiative “captures the aspirations of youth eager to go beyond traditional boundaries in innovation and startups. It embodies both rigour and relevance, truly inspiring in its mission and impact.”

AIM, through its Atal Community Innovation Centres (ACIC) programme has envisaged serving the unserved/underserved areas of the country, providing support to every grassroots innovator, and working towards accelerating the pathway to reach SDGs 2030.

ALSO READ:  Samsung sets up development team for high bandwidth memory chips

“These innovators serve as role models not only for their communities but also for society at large. I’m delighted to witness each business prospering — it’s like shaping raw gold into a precious jewel,” said Anurag Pratap Singh, Vice President & CSR Leader at Capgemini India.

Dr. Suresh Reddy, Lead CSR & Director at SRF Foundation, reflected on the impact of social entrepreneurship in addressing community challenges.

–IANS

rvt/rad

Continue Reading

Trending